Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy

被引:14
|
作者
Bedke, Jens [1 ]
Chun, Felix K-H [3 ]
Merseburger, Axel [4 ]
Scharpf, Marcus [2 ]
Kasprzyk, Kathrin [1 ]
Schilling, David [1 ]
Sievert, Karl-Dietrich [1 ]
Stenzl, Arnulf [1 ]
Kruck, Stephan [1 ]
机构
[1] Univ Tubingen, Dept Urol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Inst Pathol, D-72076 Tubingen, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[4] Hannover Med Sch, Dept Urol & Urooncol, Hannover, Germany
关键词
renal cell cancer; systemic inflammation; biomarkers; CRP; WBC; threshold; predictive accuracy; CANCER-SPECIFIC SURVIVAL; VALIDATION; BIOMARKER; MORTALITY; IMPACT; MODEL;
D O I
10.1111/j.1464-410X.2012.11642.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To re-evaluate the prognostic and predictive significance of the preoperative white blood cell (WBC) count and C-reactive protein (CRP) that independently predicts patient prognosis and to determine optimal threshold values for CRP. PATIENTS AND METHODS From 1996 to 2005, 327 patients with surgery for clear cell renal cell carcinoma were retrospectively evaluated. Cox proportional hazard models were used, adjusted for the effects of tumour stage, size, Fuhrman grade and Karnofsky index, to evaluate the prognostic significance of WBC count and CRP and to identify threshold values. Identified thresholds were correlated with clinicopathological parameters and used to estimate cancer-specific survival. To prove any additional predictive accuracy of the identified threshold it was compared with a clinicopathological base model using the Harrell concordance index (c-index). RESULTS In univariable analyses WBC count was a significant prognostic marker at a concentration of 9.5/mu L (hazard ratio [HR] 1.83) and 11.0/mu L (HR 2.09) and supported CRP values of 0.25 mg/dL (HR 6.47, P < 0.001) and 0.5 mg/dL (HR 7.15, P < 0.001) as potential threshold values. If adjusted by the multivariable models WBC count showed no clear breakpoint, but a CRP value of 0.25 mg/dL (HR 2.80, P = 0.027) proved to be optimal. Reduced cancer-specific survival was proved for CRP 0.25 mg/dL (median 69.9 vs 92.3 months). Median follow-up was 57.5 months with 72 (22%) tumour-related deaths. The final model built by the addition of CRP 0.25 mg/dL did not improve predictive accuracy (c-index 0.877) compared with the clinicopathological base model (c-index 0.881) which included TNM stage, grading and Karnofsky index. CONCLUSIONS Multivariable analyses revealed that an optimal breakpoint of CRP at a value of 0.25 mg/dL was best to stratify patients at risk of cancer-specific mortality, but CRP 0.25 mg/dL added no additional information in the prediction model. Therefore we cannot recommend measuring CRP as the traditional parameters of TNM stage, grading and Karnofsky index are already of high predictive accuracy.
引用
收藏
页码:E771 / E777
页数:7
相关论文
共 50 条
  • [41] Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma
    de Martino, Michela
    Pantuck, Allan J.
    Hofbauer, Sebastian
    Waldert, Matthias
    Shariat, Shahrokh F.
    Belldegrun, Arie S.
    Klatte, Tobias
    JOURNAL OF UROLOGY, 2013, 190 (06) : 1999 - 2004
  • [42] Clinical significance of preoperative C-reactive protein and squamous cell carcinoma antigen levels in patients with penile squamous cell carcinoma
    Li, Zai-Shang
    Yao, Kai
    Li, Yong-Hong
    Chen, Jie-Ping
    Deng, Chuang-Zhong
    Zhao, Qi
    Chen, Peng
    Wang, Bin
    Mi, Qi-Wu
    Liu, Zhuo-Wei
    Qin, Zi-Ke
    Han, Hui
    Zhou, Fang-Jian
    BJU INTERNATIONAL, 2016, 118 (02) : 272 - 278
  • [43] Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
    Yasuda, Yosuke
    Saito, Kazutaka
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Urakami, Shinji
    Yamamoto, Shinya
    Yonese, Junji
    Takahashi, Shunji
    Fukui, Iwao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 884 - 889
  • [44] Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
    Deng, Jian
    Tu, Shengyuan
    Li, Lin
    Li, Gangli
    Zhang, Yinhui
    CANCER REPORTS, 2024, 7 (06)
  • [45] The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma
    Zhang, Fan
    Ma, Xin
    Li, Huizi
    Guo, Gang
    Li, Pengfei
    Li, Hongzhao
    Gu, Liangyou
    Li, Xintao
    Chen, Luyao
    Zhang, Xu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (06) : 392 - 400
  • [46] Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
    Xu, Hua
    Xu, Wen-Hao
    Ren, Fei
    Wang, Jun
    Wang, Hong-Kai
    Cao, Long
    Shi, Guo-Hai
    Qu, Yuan-Yuan
    Zhang, Hai-Liang
    Ye, Ding-Wei
    AGING-US, 2020, 12 (01): : 866 - 883
  • [47] A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung Cancer
    Zeng, Qiuyao
    Xue, Ning
    Dai, Danian
    Xing, Shan
    He, Xia
    Li, Shibing
    Du, Yi
    Huang, Chumei
    Li, Linfang
    Liu, Wanli
    JOURNAL OF CANCER, 2017, 8 (05): : 744 - 753
  • [48] Prognostic impact of elevated preoperative C-reactive protein on patients with differentiated thyroid carcinoma
    Shimura, Tatsuo
    Shibata, Masahiko
    Gonda, Kenji
    Matsumoto, Yoshiko
    Nakano, Keiichi
    Iwadate, Manabu
    Suzuki, Satoshi
    Suzuki, Shinichi
    JOURNAL OF SURGICAL RESEARCH, 2018, 231 : 338 - 345
  • [49] Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
    Ma, Xuzhan
    Sun, Libin
    JOURNAL OF CANCER, 2023, 14 (05): : 793 - 808
  • [50] Impact of Postoperative C-Reactive Protein Level on Recurrence and Prognosis in Patients With N0M0 Clear Cell Renal Cell Carcinoma
    Ito, Keiichi
    Yoshii, Hidehiko
    Sato, Akinori
    Kuroda, Kenji
    Asakuma, Junichi
    Horiguchi, Akio
    Sumitomo, Makoto
    Asano, Tomohiko
    JOURNAL OF UROLOGY, 2011, 186 (02) : 430 - 435